Pharmacokinetics of scopolamine in serum and subcutaneous adipose tissue in healthy volunteers

International Journal of Clinical Pharmacology and Therapeutics

Volumn 43, Issue 3, 2005, Pages 134-139

  Stetina, P M ^a   Madai, B ^b   Kulemann, V ^a   Kirch, W ^b   Joukhadar, Christian ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Clinical study; Human; In vivo microdialysis; Interstitium; Scopolamine

Indexed keywords

SCOPOLAMINE BROMIDE;

ACCOMMODATION; ADIPOSE TISSUE; ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIALYSATE LEVEL; DISTRIBUTION VOLUME; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DRUG TISSUE LEVEL; DRUG TOLERABILITY; FATIGUE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; INTERSTITIAL FLUID; INTERSTITIUM; LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NORMAL HUMAN; OPEN STUDY; SUBCUTANEOUS TISSUE; TANDEM MASS SPECTROMETRY; VARIANCE; VISUAL DISORDER; VOLUNTEER;

EID: 15844402334     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP43134     Document Type: Article

References (11)

1. Clough GF, Boutsiouki P, Church MK, Michel CC 2002 Effects of blood flow on the in vivo recovery of a small diffusible molecule by microdialysis in human skin. J Pharmacol Exp Ther 302: 681-686
2. Ebert U, Kirch W 1998 Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur J Clin Invest 28: 944-949
3. Ebert U, Siepmann M, Oertel R, Wesnes KA, Kirch W 1998 Pharmacokinetics and pharmacodynamics of scopolamine after subcutaneous administration. J Clin Pharmacol 38: 720-726
4. Ebert U, Grossmann M, Oertel R, Gramatte T, Kirch W 2001 Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers. J Clin Pharmacol 41: 51-60
5. Joukhadar C, Frossard M, Mayer BX, Brunner M, Klein N, Siostrzonek P, Eichler HG, Muller M 2001 Impaired target site penetration of β-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med 29: 385-391
6. Kanto J, Klotz U 1988 Pharmacokinetic implications for the clinical use of atropine, scopolamine and glycopyrrolate. Acta Anaesthesiol Scand 32: 69-78
7. Kanto J, Kentala E, Kaila T, Pihlajamäki K 1989 Pharmacokinetics of scopolamine during caesarean section: relationship between serum concentration and effect. Acta Anaesthesiol Scand 33: 482-486
8. Muller M, Rohde B, Kovar A, Georgopoulos A, Eichler HG, Derendorf H 1997 Relationship between serum and free interstitial concentrations of cefodizime and cefpirome in muscle and subcutaneous adipose tissue of healthy volunteers measured by microdialysis. J Clin Pharmacol 37: 1108-1113
9. Oertel R, Richter K, Ebert U, Kirch W 2002 Determination of scopolamine in human serum and microdialysis samples by liquid chromatography-tandem mass spectrometry. J Chromatography B 750: 121-128
10. Putcha L, Cintron NM, Tsui J, Vanderploeg JM, Kramer WG 1989 Pharmacokinetics and oral bioavailability of scopolamine in normal subjects. Pharm Res 6: 481-485
11. Stahle L, Arner P, Ungerstedt U 1991 Drug distribution studies with microdialysis. III: Extracellular concentration of caffeine in adipose tissue in man. Life Sci 49: 1853-1858